Vertex Pharmaceuticals (VRTX) Asset Writedowns and Impairment (2009 - 2025)
Vertex Pharmaceuticals (VRTX) recorded quarterly Asset Writedowns and Impairment of $379.0 million in Q1 2025, up 4481.5% quarter-over-quarter from -$8.6 million in Q4 2019.
Vertex Pharmaceuticals (VRTX) Asset Writedowns and Impairment (2009 - 2025) Analysis & Trends
Vertex Pharmaceuticals' Asset Writedowns and Impairment history runs 10 years deep, the most recent figure standing at $379.0 million for Q1 2025.
- In Q1 2025, Asset Writedowns and Impairment changed N/A year-over-year to $379.0 million; the TTM figure through Dec 2025 stood at $379.0 million (changed N/A YoY), while the FY2025 annual figure was $379.0 million, changed N/A from the prior year.
- Asset Writedowns and Impairment was $379.0 million for Q1 2025 at Vertex Pharmaceuticals, up from -$8.6 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $379.0 million in Q1 2025 to a low of $379.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 379.00 Mn |
| Mar 31, 2025 | 379.00 Mn |
| Dec 31, 2019 | -8.65 Mn |
| Dec 31, 2019 | -8.65 Mn |
| Sep 30, 2019 | 1.61 Mn |
| Sep 30, 2019 | 1.61 Mn |
| Jun 30, 2019 | 5.77 Mn |
| Jun 30, 2019 | 5.77 Mn |
| Mar 31, 2019 | 1.27 Mn |
| Mar 31, 2019 | 1.27 Mn |
| Dec 31, 2018 | 29.00 Mn |
| Dec 31, 2018 | 29.00 Mn |
| Sep 30, 2017 | 255.30 Mn |
| Sep 30, 2017 | 255.30 Mn |
| Dec 31, 2015 | -23,000.00 |
| Dec 31, 2015 | -23,000.00 |
| Dec 31, 2014 | 711,000.00 |
| Dec 31, 2014 | 711,000.00 |
| Dec 31, 2013 | 250.60 Mn |
| Dec 31, 2013 | 250.60 Mn |